Orthocell Ltd

OCC

Company Profile

  • Business description

    Orthocell Ltd is a regenerative medicine company. The company is engaged in the development and commercialization of biological medical devices, cell therapies, and related technologies to address unmet clinical needs in human health in the regenerative medicine industry. Its product includes Striate plus; Remplir, which is a collagen wrap used in peripheral nerve repair; and OrthoACI, an implant used for the treatment of articular cartilage defects in the knee and ankle. It also has various other products in its pipeline, such as Tendon Cell Therapy and Collagen Medical Device Platform.

  • Contact

    90 South Street
    Building 191, Murdoch University
    Murdoch
    PerthWA6150
    AUS

    T: +61 893602888

    https://www.orthocell.com.au

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    30 June 2026

    Employees

Stocks News & Analysis

stocks

After earnings, is Microsoft a buy, a sell, or fairly valued?

With third-quarter results surpassing even high-end expectations, here’s what we think of Microsoft stock.
stocks

Albemarle earnings: Shares rally on strong profit growth well above consensus estimates

Albemarle should see sequential profit growth in the second quarter and maintain higher profits through the year.
stocks

Ahead of IPOs, AI giants keep making circular deals. Here’s why that’s a risk

With OpenAI reportedly missing revenue targets, the imbalanced risks of circular deals become clearer.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,980.5031.60-0.35%
CAC 408,112.5789.51-1.09%
DAX 4024,338.63324.98-1.32%
Dow JONES (US)49,609.1612.190.02%
FTSE 10010,233.0743.88-0.43%
HKSE26,393.71232.57-0.87%
NASDAQ26,247.08440.881.71%
Nikkei 22562,713.65120.19-0.19%
NZX 50 Index13,133.3941.74-0.32%
S&P 5007,398.9361.820.84%
S&P/ASX 2008,744.4036.40-0.41%
SSE Composite Index4,179.950.14-0.00%

Market Movers